Mindfulness may lift postnatal depression without pills
NCT ID NCT04332146
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether an 8-week mindfulness program could reduce depressive symptoms in new mothers. 70 women in Hong Kong with mild to moderate postnatal depression were split into two groups: one took the mindfulness course, the other received a booklet with general advice. Researchers measured depression, anxiety, stress, and quality of life at the start, after 8 weeks, and 3 months later. The goal was to see if mindfulness offers a safe, drug-free way to help mothers feel better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mindfulness-based program
- What this could lead to
- If it works, this could offer a safe, non-drug option to help new mothers feel better without medication side effects.
- What could go wrong
- This is a small, early study with only 70 participants. The results may not apply to all women, and the benefit over simple education is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTNATAL DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Queen Mary Hospital
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mothers share their stories: did therapy groups help after baby blues?
- Can a Brain-Training group ease postpartum depression?
- Singing together online lifts postnatal depression in new moms
- Could a 3-Day pill ease severe postpartum depression?
- New pill shows promise for severe postpartum depression in phase 3 trial
- New study aims to ease depression and anxiety in expecting and new mothers